ALT Latest Press Releases

-- October 27, 2026 --

Altimmune Appoints Peter Greenleaf and Alex Howarth, Two Leading Biotech Executives, to Board of Directors to Support Its Strategic Evolution Globe Newswire 8:00 AM

-- October 19, 2026 --

Altimmune to Present New Data on Pemvidutide in Serious Liver Diseases at AASLD The Liver Meeting 2026 Globe Newswire 8:00 AM

-- September 23, 2026 --

Altimmune to Participate in Stifel Cardiometabolic Forum Globe Newswire 8:00 AM

-- September 3, 2026 --

Altimmune to Participate in the Wells Fargo 21st Annual Healthcare Conference Globe Newswire 8:00 AM

-- August 12, 2026 --

Altimmune Announces Second Quarter 2026 Financial Results and Business Update Globe Newswire 7:30 AM

-- August 5, 2026 --

Altimmune to Report Second Quarter 2026 Financial Results and Provide Business Update on August 12, 2026 Globe Newswire 8:00 AM

-- August 3, 2026 --

Altimmune Initiates PERFORMA Phase 3 Trial of Pemvidutide in Patients with MASH Globe Newswire 8:00 AM

-- July 28, 2026 --

Altimmune Announces Positive Topline Results from RECLAIM Phase 2 Trial of Pemvidutide in Alcohol Use Disorder Globe Newswire 7:00 AM

Market Data Delayed 15 Minutes